HIGHLIGHTS
- who: Hawassa et al. from the University Comprehensive Specialized Hospital in have published the article: Could a Dolutegravir-Based Antiretroviral Therapy Lead to Clinical Obesity? A Retrospective Cohort Study Conducted at Hawassa University Comprehensive Specialized Hospital in Hawassa, Sidama, Ethiopia, in the Journal: AIDS Research and Treatment of 13/05/2022
- what: The main reasons why this new medication was preferred over the existing medication were the good safety profile, rapid suppression of viral load, and high genetic variability for resistance, to mention a few . The authors evaluated 422 HIV/AIDS patients, equally divided into . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.